Reva Medical’s coronary scaffold has been designed to offer ease-of-use features, including complete scaffold visibility under x-ray
Cardio
New Money Fuels Direct Flow’s U.S. Clinicals and International Growth
Transcatheter heart valve innovator Direct Flow Medical®, Inc., has announced the closing of a new round of financing for the company totaling $32 million.
Want to Know Whether Specific Biotronik Implant is MRI Compatible?
Biotronik, is launching ProMRI® SystemCheck, a new online tool for tracking the ProMRI status of implantable devices.
Research Suggests Coronary Stents Market Worth $5.61 Billion by 2020
If you keep a regular finger on the pulse of the coronary stent market you’ll need to decide whether you’ll learn much from these reports, but you pays your money….
Boston Scientific SYNERGY™ Bioabsorbable Polymer Stent Meets Key Performance Endpoints
Boston Scientific reports that its SYNERGY™ Everolimus-Eluting Bioabsorbable Polymer Platinum Chromium Coronary Stent System met its primary endpoint in the first successful U.S. pivotal trial of a bioabsorbable polymer stent.
CardioMEMS™ HF Heart Monitoring Significantly Reduced 30-Day Hospital Readmission Rates
A retrospective data analysis from a study into St. Jude’s CardioMEMS™ HF monitoring sensor shows significant a reduction in 30-day hospital readmission rates for patients age 65 and older.
Studies Presented at AHA Conclude CRT Therapy Extends Life, Reduces Hospital Readmissions
New data point to the clinical and economic value of Medtronic’s cardiac resynchronization therapy devices for the treatment of heart failure.
First in Man Use of MANTA™ Large Bore Vascular Closure Device
Essential Medical reports on the initial First in Man studies for its revolutionary MANTA Large Bore Vascular Closure device, which is designed to seal 18F large bore femoral punctures.
FDA Approves Pivotal Study to Investigate Dual Ablation Approach in Non-Paroxysmal Afib Patients
AtriCure will investigate a minimally invasive approach to treat patients with persistent or long-standing persistent atrial fibrillation who have failed antiarrhythmic drug therapy.
Stentys Plugs Gap with MiStent Drug Eluting Stent Distribution Deal
Stentys will offer MiStent SES® for routine procedures, reserving its own Self-Apposing® stent for complex anatomies.
Medtronic Points to Improved Deliverability with EU Launch of Resolute Onyx™ DES
First and Only DES with Novel CoreWire Technology Allows for Thinner, Stronger Struts, Enhanced Deliverability and Radiopacity without Compromising Structural Strength
Sorin’s RESPOND CRT IDE Clinical Trial Completes Enrollment
Can CRT optimization using SonR heart sensor improve outcome in heart failure patients? A significant study, now fully enrolled, should tell us.
FDA Nod is Validation of MGuard Prime EPS Manufacturing Changes, Says InspireMD
The FDA has approved manufacturing process changes to InspireMD’s MGuard Prime EPS that were proposed in response to April Voluntary Field Action
Abbott Dives Into Catheter-Based Electrophysiology Through Acquisition
Abbott is to acquire Topera with its clever diagnostic catheter and mapping software that offers improved outcomes from cardiac ablation for atrial fibrillation.
FDA Approval for St. Jude’s TactiCath Quartz Contact Force Ablation Catheter for AF
TactiCath Quartz contact-force technology provides physicians with more control of contact force during ablation procedures in order to create more effective lesions in paroxysmal AF treatment.
CE Mark and First Implant of Sorin’s MEMO 3D ReChord™
Sorin Group has gained CE mark certification for its new MEMO 3D ReChord™ mitral valve annuloplasty ring, which it is making immediately available in Europe.